 
|
|
TB/HIV Working Group |
|
Home | TB/HIV Working Group | Meetings and Events | Key Issues in implementation | Publications | Contact Us
|
|
|
If you have TB/HIV Operational research study results you would like to share please tell us about it in one paragraph. Contact us at: tbhiv@who.int |
TB/HIV Research PrioritiesTB/HIV research aims to better understanding the magnitude and burden of TB in HIV prevalent settings, to accelerating universal and effective implementation of collaborative TB/HIV activities, and to preventing unnecessary morbidity and mortality due to TB among people living with HIV. It embraces many aspects of research, from clinical to operational research and development of new technologies. TB/HIV research should be made a priority by both HIV and TB research establishments and their funding agencies. Knowledge gaps in preventing, diagnosing and treating childhood TB/HIV co-infection or drug-resistant TB among people living with HIV are just some examples of the unmet research needs. Researchers, funding bodies and national governments should commit without any further delay to address gaps and priorities in TB/HIV research. The Secretariat in collaboration with other partners organizes meetings with HIV and TB researchers to raise the profile of HIV/TB research. It has also initiated the process to define and revise the priorities for HIV/TB research. TB/HIV at IAS 2009: Catalysing HIV/TB Research: innovation, funding and networkingThe World Health Organization and the TB/HIV Working Group of the Stop TB Partnership in collaboration with the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE), International AIDS Society, Treatment Action Group and the Desmond Tutu HIV Centre of University of Cape Town organized a highly visible meeting in conjunction with the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Cape Town, South Africa on July 18-19, 2009. The meeting was attended by about 250 HIV researchers, activists and representatives from funding agencies. The meeting focused on critical TB/HIV issues in the areas of TB prevention, diagnosis and treatment, childhood TB and drug resistant TB. New and previously unreported data was shared, discussed and research priorities were defined. The research priority discussions during the meeting also informed the ongoing revision of the TB/HIV research priorities document by the World Health Organisation, which will soon be finalised. Presentations from the meeting are available at here. The outcome and key findings of the meeting were communicated to the IAS conference delegates through a satellite symposium on July 21, 2009. Webcast of the satellite symposium is available at http://www.ias2009.org/pag/webcasts/?sessionid=2449 TB/HIV at CROI 2009The Stop TB Department of WHO in collaboration with the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE) organized a meeting affiliated with the 16th Conference on Retroviruses and Opportunistic Infections (CROI 2009) in Montreal, Canada. This is the third in a series of meetings organized since 2007. The meetings have successfully raised the profile of HIV/TB among HIV researchers in particular by sharing data from ongoing studies, identifying research gaps and stimulating further HIV/TB research. The main objective of the meeting at CROI 2009 was to promote high level scientific interchange of ideas and research priorities to have a better understanding of the magnitude and burden of TB (including drug resistant strains) especially in HIV prevalent settings. List of participantsRead the presentations made at the meetingPK and Drug Interactions in a Changing World: New Drugs for TB and New Regimens for TB-HIV Co-infection by Charles Flexner, MD, Johns Hopkins University |
|
